Fresenius Kabi Expands Production Site in Portugal
Fresenius Kabi has added two new antibiotics production lines at its plant in Santiago de Besteiros, Portugal.
Fresenius Kabi announced that it has added two new antibiotics production lines at its plant in Santiago de Besteiros, Portugal. The two lines, for production of intravenous penicillin, will be housed in a new 6000-square-meter (almost 65,000-square-foot) building. Fresenius Kabi invested approximately €17 million in this expansion. Approximately 80 new jobs will be created at the Santiago de Besteiros plant from this expansion, according to the company.
Special guests Manuel Delgado, Secretary of State of Health, and João Vasconcelos, Secretary of State of Industry, represented the national government at the opening ceremony.
Fresenius Kabi’s Santiago de Besteiros plant manufactures various pharmaceuticals, such as antibiotics and infusion solutions. As one of Portugal’s largest pharmaceutical production sites, it employs approximately 600 staff.
Source: Fresenius Kabi
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
